Pidilite Industries Ltd
Pidilite Industries Limited is a leading manufacturer of adhesives and sealants, construction chemicals, craftsmen products, DIY products and polymer emulsions in India. Most of the products have been developed through strong in-house R&D. Our brand name Fevicol has become synonymous with adhesives to millions in India and is ranked amongst the most trusted brands in the country. Some of our other major brands are M-Seal, Fevikwik, Fevistik, Roff, Dr. Fixit, Fevicryl, Motomax, Hobby Ideas, Araldite. [1]
- Market Cap ₹ 1,62,004 Cr.
- Current Price ₹ 3,185
- High / Low ₹ 3,415 / 2,488
- Stock P/E 82.6
- Book Value ₹ 171
- Dividend Yield 0.50 %
- ROCE 29.7 %
- ROE 22.8 %
- Face Value ₹ 1.00
Pros
- Company is almost debt free.
- Company has been maintaining a healthy dividend payout of 44.4%
- Company's working capital requirements have reduced from 41.8 days to 24.3 days
Cons
- Stock is trading at 18.6 times its book value
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Chemicals Industry: Chemicals
Part of Nifty 500 Multicap 50:25:25 BSE Commodities Nifty 100 Equal Weight BSE Allcap Nifty100 ESG
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3,678 | 4,283 | 4,844 | 5,361 | 5,617 | 6,078 | 7,078 | 7,294 | 7,293 | 9,921 | 11,799 | 12,383 | 12,662 | |
3,120 | 3,611 | 4,073 | 4,188 | 4,355 | 4,737 | 5,707 | 5,718 | 5,606 | 8,065 | 9,813 | 9,675 | 9,765 | |
Operating Profit | 558 | 672 | 771 | 1,173 | 1,262 | 1,341 | 1,371 | 1,576 | 1,686 | 1,856 | 1,986 | 2,708 | 2,897 |
OPM % | 15% | 16% | 16% | 22% | 22% | 22% | 19% | 22% | 23% | 19% | 17% | 22% | 23% |
107 | 38 | 40 | 81 | 115 | 153 | 130 | 97 | 74 | 39 | 55 | 63 | 125 | |
Interest | 16 | 16 | 16 | 13 | 14 | 16 | 26 | 34 | 37 | 42 | 48 | 51 | 50 |
Depreciation | 69 | 81 | 118 | 100 | 115 | 120 | 133 | 170 | 201 | 240 | 270 | 341 | 364 |
Profit before tax | 581 | 612 | 678 | 1,141 | 1,248 | 1,359 | 1,342 | 1,470 | 1,522 | 1,614 | 1,723 | 2,379 | 2,608 |
Tax % | 27% | 27% | 25% | 29% | 31% | 29% | 31% | 24% | 26% | 25% | 25% | 27% | |
424 | 450 | 514 | 807 | 863 | 966 | 928 | 1,122 | 1,126 | 1,207 | 1,289 | 1,747 | 1,927 | |
EPS in Rs | 8.27 | 8.77 | 10.00 | 15.66 | 16.77 | 18.95 | 18.21 | 21.97 | 22.26 | 23.76 | 25.05 | 34.00 | 37.61 |
Dividend Payout % | 31% | 31% | 29% | 26% | 28% | 32% | 36% | 32% | 38% | 42% | 44% | 47% |
Compounded Sales Growth | |
---|---|
10 Years: | 11% |
5 Years: | 12% |
3 Years: | 19% |
TTM: | 5% |
Compounded Profit Growth | |
---|---|
10 Years: | 15% |
5 Years: | 14% |
3 Years: | 16% |
TTM: | 30% |
Stock Price CAGR | |
---|---|
10 Years: | 21% |
5 Years: | 19% |
3 Years: | 10% |
1 Year: | 20% |
Return on Equity | |
---|---|
10 Years: | 24% |
5 Years: | 22% |
3 Years: | 21% |
Last Year: | 23% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 51 | 51 | 51 | 51 | 51 | 51 | 51 | 51 | 51 | 51 | 51 | 51 | 51 |
Reserves | 1,600 | 1,901 | 2,219 | 2,587 | 3,420 | 3,523 | 4,097 | 4,405 | 5,542 | 6,353 | 7,161 | 8,356 | 8,664 |
111 | 46 | 58 | 80 | 98 | 125 | 113 | 288 | 331 | 416 | 391 | 382 | 379 | |
853 | 930 | 986 | 996 | 1,202 | 1,500 | 1,643 | 1,779 | 2,890 | 2,675 | 2,902 | 3,286 | 3,662 | |
Total Liabilities | 2,616 | 2,928 | 3,315 | 3,714 | 4,770 | 5,199 | 5,904 | 6,523 | 8,814 | 9,494 | 10,505 | 12,076 | 12,755 |
646 | 729 | 978 | 1,137 | 1,275 | 1,342 | 1,448 | 1,807 | 4,418 | 4,703 | 4,914 | 5,451 | 5,499 | |
CWIP | 428 | 458 | 462 | 158 | 148 | 228 | 242 | 259 | 294 | 225 | 406 | 148 | 161 |
Investments | 294 | 260 | 370 | 706 | 1,443 | 1,246 | 1,548 | 1,186 | 516 | 459 | 881 | 2,235 | 2,546 |
1,248 | 1,481 | 1,505 | 1,713 | 1,904 | 2,383 | 2,666 | 3,270 | 3,586 | 4,107 | 4,304 | 4,242 | 4,550 | |
Total Assets | 2,616 | 2,928 | 3,315 | 3,714 | 4,770 | 5,199 | 5,904 | 6,523 | 8,814 | 9,494 | 10,505 | 12,076 | 12,755 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
472 | 394 | 552 | 907 | 794 | 796 | 845 | 1,280 | 1,392 | 955 | 1,558 | 2,724 | |
-144 | -99 | -436 | -491 | -879 | 39 | -513 | 103 | -1,688 | -558 | -899 | -1,769 | |
-339 | -242 | -165 | -371 | 41 | -790 | -361 | -849 | -76 | -468 | -656 | -742 | |
Net Cash Flow | -12 | 54 | -49 | 45 | -45 | 46 | -29 | 533 | -372 | -71 | 2 | 212 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 43 | 45 | 44 | 48 | 50 | 56 | 54 | 54 | 66 | 53 | 47 | 49 |
Inventory Days | 95 | 93 | 88 | 89 | 100 | 102 | 95 | 100 | 133 | 114 | 98 | 86 |
Days Payable | 45 | 54 | 45 | 53 | 54 | 69 | 59 | 67 | 109 | 70 | 57 | 70 |
Cash Conversion Cycle | 92 | 84 | 86 | 84 | 96 | 89 | 90 | 88 | 91 | 96 | 88 | 66 |
Working Capital Days | 23 | 33 | 31 | 42 | 46 | 56 | 54 | 45 | 35 | 54 | 47 | 24 |
ROCE % | 34% | 33% | 32% | 45% | 39% | 36% | 33% | 33% | 28% | 25% | 24% | 30% |
Documents
Announcements
- Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate 2d
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
11 Dec - Schedule of Analyst/Institutional Investor Meetings.
- Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS 10 Dec
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
26 Nov - Of Schedule of Analyst/Institutional Investor Meetings under the SEBI (LODR) Regulations, 2015
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
25 Nov - Schedule of Analyst/Institutional Investor Meetings on 02 Dec 2024.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from nse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2012
from nse
Concalls
-
Oct 2024Transcript PPT REC
-
Aug 2024Transcript PPT REC
-
May 2024Transcript PPT REC
-
May 2024TranscriptNotesPPT
-
Mar 2024TranscriptNotesPPT
-
Jan 2024Transcript PPT
-
Nov 2023Transcript PPT
-
Aug 2023Transcript PPT
-
Aug 2023TranscriptNotesPPT
-
May 2023Transcript PPT
-
May 2023TranscriptNotesPPT
-
Feb 2023Transcript PPT
-
Jan 2023TranscriptNotesPPT
-
Nov 2022Transcript PPT
-
Aug 2022Transcript PPT
-
May 2022Transcript PPT
-
Feb 2022Transcript PPT
-
Jan 2022TranscriptNotesPPT
-
Nov 2021Transcript PPT
-
Aug 2021Transcript PPT
-
May 2021Transcript PPT
-
Feb 2021Transcript PPT
-
Feb 2021Transcript PPT
-
Dec 2020Transcript PPT
-
Nov 2020Transcript PPT
-
Aug 2020TranscriptNotesPPT
-
Aug 2020Transcript PPT
-
Aug 2020Transcript PPT
-
Jun 2020Transcript PPT
-
Jun 2020TranscriptNotesPPT
-
Feb 2020Transcript PPT
-
Feb 2020Transcript PPT
-
Jan 2020TranscriptNotesPPT
-
Dec 2019TranscriptPPT
-
Nov 2019Transcript PPT
-
Nov 2019TranscriptNotesPPT
-
Aug 2019TranscriptPPT
-
Aug 2019Transcript PPT
-
Jul 2019TranscriptNotesPPT
-
Jun 2019Transcript PPT
-
May 2019Transcript PPT
-
Feb 2019Transcript PPT
-
Jan 2019Transcript PPT
-
Nov 2018TranscriptPPT
-
Nov 2018Transcript PPT
-
Sep 2018Transcript PPT
-
Aug 2018Transcript PPT
-
Aug 2018TranscriptNotesPPT
-
Jun 2018Transcript PPT
-
Jun 2018Transcript PPT
-
Feb 2018Transcript PPT
-
Feb 2018Transcript PPT
-
Jan 2018TranscriptNotesPPT
-
Nov 2017TranscriptPPT
-
Nov 2017Transcript PPT
-
Sep 2017Transcript PPT
-
Aug 2017Transcript PPT
-
May 2017Transcript PPT
-
Feb 2017Transcript PPT
-
Feb 2017TranscriptNotesPPT
-
Nov 2016Transcript PPT
-
Aug 2016Transcript PPT
-
Jun 2016Transcript PPT
-
May 2016Transcript PPT
-
Feb 2016Transcript PPT
Revenue Breakup
Company earns about 53% of its revenues from adhesives & sealants category, followed by Construction & paint chemicals (20%), industrial resins & construction chemicals (7%), art & craft materials (6%), industrial adhesives (6%), and pigment & preparation (6%)..
It has its business divided into 2 divisions, consumer & bazaar products which account for ~80% of revenues, and B2B products segment which accounts for ~20% of revenues [1] In total,the company produces ~6500 products for its brands. [2]